Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer Female
Interventions: DRUG: Tamoxifen|DRUG: Toremifene
Sponsor: Chinese Anti-Cancer Association
Collaborators: Fudan University|Henan Cancer Hospital|The First Hospital of Jilin University|Southwest Hospital, China|First Hospital of China Medical University|Guangdong Provincial People's Hospital|Harbin Medical University|First Affiliated Hospital of Chongqing Medical University|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University|Jiangsu Provincial People's Hospital|Cancer Institute and Hospital, Chinese Academy of Medical Sciences|Zhejiang Cancer Hospital|Tianjin Medical University Cancer Institute and Hospital|Union hospital of Fujian Medical University|Hebei Tumor Hospital|Hunan Cancer Hospital|Affiliated Hospital of Qinghai University|Wuhan TongJi Hospital|Hainan People's Hospital|The Third Affiliated Hospital of Kunming Medical College.|The Third Affiliated Hospital of Nanchang University